Massive clinical studies for Cresto reconfirmed its safety and efficacy.

Published: 2003-06-12 06:56:00

Updated: 2003-06-12 06:56:00

The efficacy and safety of Cresto (Losuvastatin) developed by AstraZeneca for the lowering of high cholesterol blood levels was reported during the 2nd Asia and Pacific Science Forum held in Honolulu.

The data collected from more than 15,000 patients who took part in the clinical studies for ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK